ICD-10

ICD-10 code C69.80

You are here: Home > ICD-10-CM > C00-D49 > C00-C96 > C00-C75 > C69-C72 > C69 > C69.8

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- C00-D49
Neoplasms
- C00-C96
Malignant neoplasms
- C00-C75
Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue
- C69-C72
Malignant neoplasms of eye, brain and other parts of central nervous system
- C69
Malignant neoplasm of eye and adnexa
- C69.8
Malignant neoplasm of overlapping sites of eye and adnexa

C69.80

Malignant neoplasm of overlapping sites of unspecified eye and adnexa

ICD-10 code C69.80 for Malignant neoplasm of overlapping sites of unspecified eye and adnexa

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us